News Overview

GIO Therapeutics


GIO Therapeutics specialises in the development of G protein-coupled receptor (GPCR)-targeted pharmaceuticals. GIO’s innovative approach positions them to address complex challenges in oncology and inflammatory diseases. Its focus is not only to discover but to significantly improve patient outcomes.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.